Schwab International Index Fund
SCHWAB CAPITAL TRUST · 1 share class
Fund classification
Classified from what the fund holds · as of 2026 Q2
Schwab International Index Fund is a developed international equity index fund that tracks the MSCI EAFE Index.
- Asset class
- Equity
- Region
- Developed international
- Management
- Index (passive)
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q1
The funds goal is to track the performance of a benchmark index that measures the total return of large, publicly traded non-U.S. companies from countries with developed equity markets outside of the United States.
The fund tracks the MSCI EAFE Index by holding the same stocks at the same weights, adjusting weightings only to manage transaction costs, taxes, or liquidity. Because the fund incurs expenses and holds cash for operations while the index does not, its returns will lag the index; the fund uses futures contracts and securities lending to narrow this gap.
| Share class | Expense ratio |
|---|---|
| SWISX | 0.06% |
Portfolio turnover 10.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.07% |
| Cash & short-term | 0.64% |
| Derivatives | 0.01% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Roche Holding AG, Reckitt Benckiser Group PLC, SUNB, Tower Semiconductor Ltd, Ibiden Co Ltd, BAWAG Group AG, Shimizu Corp, Italgas SpA
Largest exited: Roche Holding AG, Reckitt Benckiser Group PLC, Ashtead Group PLC, CyberArk Software Ltd, JDE Peet's NV, DCC PLC, IMCD NV, Trend Micro Inc/Japan
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | ASML Holding NV | 2.58% | $1,445.55 | $361.26M | 249.9K |
| — | HSBC Holdings PLC | 1.46% | $18.40 | $203.57M | 11.1M |
| — | AstraZeneca PLC | 1.35% | $189.72 | $189.48M | 998.7K |
| — | Roche Holding AG | 1.32% | $407.50 | $184.43M | 452.6K |
| — | Novartis AG | 1.29% | $147.79 | $180.98M | 1.2M |
| — | Nestle SA | 1.20% | $101.24 | $167.98M | 1.7M |
| — | Shell PLC | 1.19% | $45.47 | $166.66M | 3.7M |
| — | Siemens AG | 1.04% | $297.16 | $145.35M | 489.1K |
| — | Commonwealth Bank of Australia | 0.97% | $125.96 | $135.70M | 1.1M |
| — | Mitsubishi UFJ Financial Group Inc | 0.93% | $17.96 | $130.32M | 7.3M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-04-30 — not a live quote, and not what the fund paid.
Top 10 positions are 13.34% of net assets, top 25 24.61%, across 684 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free